[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Approvals - September 2004

  ANDA Number Generic Drug Name Applicant Approval Date
1 75-987 OXAPROZIN TABLETS, USP 600 MG   TORPHARM, INC. 9/2/2004 
2 76-352 AMANTADINE HYDROCHLORIDE SYRUP, USP 50 MG/ 5 ML   SILARX PHARMACEUTICALS, INC. 9/10/2004 
3 76-372 BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION 0.2%   IVAX PHARMACEUTICALS, INC. 9/10/2004 
4 76-639 CIPROFLOXACIN TABLETS, USP 250 MG, 500 MG, AND 750 MG   UNIQUE PHARMACEUTICAL LABORATORIES 9/10/2004 
5 76-865 FLUTICASONE PROPIONATE CREAM 0.05%   KV PHARMACEUTICAL COMPANY 9/10/2004 
6 76-775 NICOTINE POLACRILEX GUM, USP (OTC) 2 MG (BASE) REGULAR FLAVOR   L. PERRIGO COMPANY 9/16/2004 
7 76-776 NICOTINE POLACRILEX GUM, USP (OTC) 2 MG (BASE) ORANGE FLAVOR   L. PERRIGO COMPANY 9/16/2004 
8 76-777 NICOTINE POLACRILEX GUM, USP (OTC) 2 MG (BASE) MINT FLAVOR   L. PERRIGO COMPANY 9/16/2004 
9 76-778 NICOTINE POLACRILEX GUM, USP (OTC) 4 MG (BASE) ORANGE FLAVOR   L. PERRIGO COMPANY 9/16/2004 
10 76-779 NICOTINE POLACRILEX GUM, USP (OTC) 4 MG (BASE) MINT FLAVOR   L. PERRIGO COMPANY 9/16/2004 
11 76-789 NICOTINE POLACRILEX GUM, USP (OTC) 4 MG (BASE) REGULAR FLAVOR   L. PERRIGO COMPANY 9/16/2004 
12 40-510 ERGOTAMINE TARTRATE AND CAFFEINE TABLETS, USP 1 MG/100 MG   WEST-WARD PHARMACEUTICAL CORP. 9/17/2004 
13 65-133 CYCLOSPORIN ORAL SOLUTION, USP 100 MG/ML   MORTON GROVE PHARMACEUTICALS, INC. 9/17/2004 
14 76-751 MESALAMINE RECTAL SUSPENSION, USP (ENEMA) 4 G/60 ML   AGIS INDUSTRIES (1983), LTD. 9/17/2004 
15 76-729 CARBAMAZEPINE ORAL SUSPENSION, USP 100 MG/5 ML   TARO PHARMACEUTICAL INDUSTRIES, LTD. 9/20/2004 
16 76-858 LEVOCARNITINE TABLETS, USP 330 MG   COREPHARMA LLC 9/20/2004 
17 76-427 MILRINONE LACTATE INJECTION 1 MG (BASE)/ML; PACKAGED IN 10 MG (BASE)/10 ML AND 20 MG (BASE)/20 ML SINGLE-DOSE VIALS   APOTEX CORP. 9/21/2004 
18 76-557 LORATADINE AND PSEUDOEPHEDRINE SULFATE EXTENDED-RELEASE TABL 10 MG/240 MG (OTC) (24-HOUR FORMULATION)   RANBAXY LABORATORIES LIMITED 9/22/2004 
19 76-925 IBUPROFEN ORAL SUSPENSION, USP 100 MG/5 ML   PERRIGO R & D COMPANY 9/23/2004 
20 65-174 CLARITHROMYCIN TABLETS, USP 250 MG AND 500 MG   RANBAXY LABORATORIES LIMITED 9/24/2004 
21 65-206 CLINDAMYCIN INJECTION, USP 150 MG/ML (PHARMACY BULK PACKAGE)   BEDFORD LABORATORIES 9/24/2004 
22 76-962 BROMOCRIPTINE MESYLATE TABLETS, USP 2.5 MG (BASE)   MYLAN PHARMACEUTICALS, INC. 9/24/2004 
23 40-415 WARFARIN SODIUM TABLETS, USP 1 MG, 2 MG, 2.5 MG, 3 MG, 4 MG, 5 MG, 6 MG, 7.5 MG, AND 10 MG   GENPHARM INC. 9/27/2004 
24 76-318 OXYCODONE HYDROCHLORIDE EXTENDED-RELEASE TABLETS 80 MG   IMPAX LABORATORIES, INC. 9/27/2004 
25 76-068 DEXRAZOXANE FOR INJECTION 250 MG AND 500 MG; PACKAGED IN SINGLE-DOSE VIALS   BEDFORD LABORATORIES 9/28/2004 
26 76-464 HALOPERIDOL INJECTION, USP 5 MG/ML; PACKAGED IN 1 ML AMPULES   SABEX 2002 INC. 9/29/2004 
27 76-783 NORETHINDRONE AND ETHINYL ESTRADIOL TABLETS, USP 0.5 MG/0.035 MG AND 1 MG/0.035 MG (28-DAY REGIMEN) (ARANELLE TABLETS)   BARR LABORATORIES, INC. 9/29/2004 
28 76-911 CLORAZEPATE DIPOTASSIUM TABLETS, USP 3.75 MG, 7.5 MG, AND 15 MG   RANBAXY LABORATORIES LIMITED 9/29/2004 
29 40-522 NOREPINEPHRINE BITARTRATE INJECTION, USP 1 MG (BASE)/ML; PACKAGED IN 4 MG (BASE)/4 ML AMPOULES   PHARMAFORCE, INC. 9/30/2004 
30 76-321 TIZANIDINE HYDROCHLORIDE TABLETS 2 MG (BASE) AND 4 MG (BASE)   IVAX PHARMACEUTICALS, INC. 9/30/2004 
31 76-841 MESALAMINE RECTAL SUSPENSION, USP (ENEMA) 4 G/60 ML   TEVA PHARMACEUTICALS USA 9/30/2004 

Back to Top      Back to Approvals

Date created: October 5, 2004

horizonal rule